Published March 1, 2025
| Version v1
Journal article
Open
Successful Use of Dupilumab in Bullous Pemphigoid: A Series of 3 Cases in Mexico
Authors/Creators
- 1. Faculty of Medicine, UNAM, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico. & Service of Dermatology, Centro Médico Nacional 20 de Noviembre, ISSSTE, Mexico City, Mexico.
Description
This review explores three recent case reports detailing the successful treatment of bullous pemphigoid (BP) with Dupilumab, a monoclonal antibody targeting interleukin-4 receptor alpha subunit (IL-4Rα). Each case highlights unique clinical presentations, treatment approaches, and outcomes, underscoring Dupilumab's potential as a therapeutic option in BP management.
Files
2156-Article Text-5658-2-10-20250301.pdf
Files
(278.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:65b61ef299f8080db6b313dacce0e8a7
|
278.9 kB | Preview Download |